Business Context and Reporting Period
Company: American Battery Technology Company (ABAT)
Filing Type: Form 8-K (Current Report)
Date of Report: November 22, 2023
Reporting Period: Event date of November 22, 2023
The Company, incorporated in Nevada and trading on The Nasdaq Stock Market LLC under the symbol "ABAT," filed this report to disclose a significant corporate event regarding a new equity offering.
Key Financial Metrics
This filing is a Current Report on Form 8-K and does not contain audited financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on the authorization of a new securities offering.
Material Changes and Events
Item 8.01 Other Events: On November 22, 2023, the Company filed a prospectus supplement related to the offer and sale of up to 2,000,000 shares of its common stock (par value $0.001 per share).
- Sale Method: Shares will be sold directly by the Company at market prices or to Tysadco Partners, LLC, pursuant to a written sales agreement.
- Legal Opinion: An opinion regarding the legality of the shares was filed as Exhibit 5.1 by Holland & Hart LLP.
- Restrictions: The filing explicitly states it does not constitute an offer to sell or a solicitation of an offer to buy in any state where such action would be unlawful prior to registration.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, earnings outlook, or management commentary regarding operational performance. The text is limited to the procedural details of the equity offering.
Risks and Contingencies: The filing notes standard securities law restrictions, stating that no offer or sale will occur in jurisdictions where it is unlawful without proper registration or qualification. No other specific risks or contingencies are detailed in this document.
Investor Verification Checklist
- Verify the terms of the sales agreement with Tysadco Partners, LLC referenced in the Prospectus Supplement (Annex A).
- Review the full Prospectus Supplement for details on the use of proceeds from the potential sale of 2,000,000 shares.
- Confirm the current market price of ABAT stock to assess the potential dilution impact of the offering.
- Check subsequent filings to determine if and when shares were actually sold under this program.